research Alopecia Areata in a Patient Receiving Infliximab
Infliximab may cause hair loss in Crohn's disease patients.
Search
for
Sort by
Research
510-540 / 578 results
research Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.
research Upadacitinib for Management of Recalcitrant Alopecia Areata: A Retrospective Case Series
Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.
research Hairlines Through History: Frontal Fibrosing Alopecia Over 500 Years
Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.
research Low Level Laser Versus Platelet-Rich Plasma in Treatment of Alopecia Areata: A Randomized Controlled Intra-Patient Comparative Study
Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.
research Serum Zinc Concentration in Patients With Alopecia Areata
People with severe hair loss have lower zinc levels in their blood.
research Anxiety, Depression and Low Self-Esteem Among People With Alopecia
People with alopecia often feel anxious, depressed, and have low self-esteem.
research Incidence and Prevalence of Alopecia Areata in the Australian Primary Care Setting: A Retrospective Analysis of Electronic Health Record Data
The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.
research Effects of Age and Sex on the Comorbidities of Alopecia Areata: A Cross-Sectional Hospital-Based Study
Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.
research Efficacy and Safety of Baricitinib in Managing Severe Alopecia Areata: A 6-Month Real-World Experience
Baricitinib was effective and safe for severe hair loss treatment over 6 months.
research Fractional Carbon Dioxide Laser Alone and as an Assisted Drug Delivery for Treatment of Alopecia Areata: A Clinical, Dermoscopic and Immunohistochemical Study
Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.
research A First Case of Childhood Chronic Inflammatory Demyelinating Polyneuropathy Associated with Alopecia Universalis
A nine-year-old girl with muscle weakness and total hair loss improved with specific treatments.
research 47-Year-Old Female with Alopecia on the Frontal and Temporal Scalp
Early treatment of traction alopecia can reverse hair loss; prevention involves avoiding tight hairstyles.
research Hair Loss in an 11-Year-Old: Successful Treatment of Alopecia Universalis with Baricitinib and Minoxidil
An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.
research PRP Therapy in Chronic Diffuse Alopecia Areata – A Case Report
PRP therapy significantly improved hair growth in a girl with chronic alopecia areata.
research Dermatopathology Quiz: Which Alopecia Does the Patient Have?
The patient has frontal fibrosing alopecia (FFA).
research Serum Granulysin as a Possible Key Marker of the Activity of Alopecia Areata
Serum granulysin levels can indicate the activity and prognosis of alopecia areata.
research Serum Vitamin D Levels and Alopecia Areata: A Hospital-Based Case-Control Study from North India
People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.
research Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.
research A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.
research Intravenous Methylprednisolone Pulse Therapy in Severe Alopecia Areata
Methylprednisolone infusions can help some people with severe alopecia regrow hair.
research Efficacy and Safety of Tofacitinib Therapy in Asian Patients with Severe Alopecia Areata
Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.
research Annular Alopecia Areata: Report of Two Cases
Two people had unusual ring-shaped hair loss due to an autoimmune disorder.
research Association Between Alopecia Areata and COVID-19: A Systematic Review
COVID-19 may be linked to hair loss or worsening of hair loss in some people.
research Successful Treatment of Alopecia Areata Barbae with Platelet-Rich Plasma
Platelet-rich plasma injections can effectively treat alopecia areata barbae.
research Triamcinolone Acetonide Mesotherapy in the Treatment of Recalcitrant Patches of Alopecia Areata: A Pilot Study
Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.
research Association Between Genetically Predicted Leukocyte Telomere Length and Non-Scarring Alopecia: A Two-Sample Mendelian Randomization Study
Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.
research Efficacy and Safety of Baricitinib in Patients With Refractory Alopecia Areata
Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.
research Study of the International Epidemiology of Androgenetic Alopecia in Young Caucasian Men Using Photographs from the Internet
research Systemic Lupus Erythematosus Presenting as Alopecia Areata
A woman's hair loss led to discovering she had lupus.